Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for authors

    Page :A6

    
• • ·Information for readers

    Page :A8

    

• Editorials

  • ·Assessing prognosis in heart failure: Is hepatocyte growth factor the next B-type natriuretic peptide?

    Page :1-3

    Jason N. Katz, Mark H. Drazner

    Plan Plan
  • ·Percutaneous coronary intervention–induced emboli during primary PCI for STEMI: Too little, too much, or too late?

    Page :4-6

    Richard E. Kuntz, Campbell Rogers, Donald S. Baim

    
  • ·Do stents reduce mortality compared with balloon angioplasty? A critical review of all the evidence

    Page :7-10

    Jassim Al Suwaidi, Peter B. Berger

    

• Progress in Cardiology

  • ·Inflammation and coronary artery disease

    Page :11-18

    Alice Y. Tiong, David Brieger

    Résumé Résumé Plan Plan  
  • ·A review of the oral direct thrombin inhibitor ximelagatran : Not yet the end of the warfarin era…

    Page :19-26

    Robert Mohapatra, Maichi Tran, Joel M. Gore, Frederick A. Spencer

    Résumé Résumé Plan Plan  

• Curriculum in Cardiology

  • ·The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients

    Page :27-34

    Niranjan Seshadri, Samuel Z. Goldhaber, Uri Elkayam, Richard A. Grimm, James B. Groce, John A. Heit, Sarah A. Spinler, Alexander G.G. Turpie, Gideon Bosker, Allan L. Klein

    Résumé Résumé Plan Plan  
  • ·Management of risk in peripheral artery disease: Recent therapeutic advances

    Page :35-40

    Daniel G. Hackam, Shaun G. Goodman, Sonia S. Anand

    Résumé Résumé Plan Plan  
  • ·Is it time to prescribe statins to patients with calcified aortic stenosis?

    Page :41-45

    Arash Rashidi, Dale S. Adler, Ward Casscells, Mohammad Madjid

    Résumé Résumé Plan Plan

• Trial Design

  • ·Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)

    Page :46-53

    John R. Teerlink, John J.V. McMurray, Robert C. Bourge, John G.F. Cleland, Gadi Cotter, Guillaume Jondeau, Henry Krum, Marco Metra, Christopher M. O'Connor, John D. Parker, Guillermo Torre-Amione, Dirk J. Van Veldhuisen, Aline Frey, Maurizio Rainisio, Isaac Kobrin, VERITAS Investigators

    Résumé Résumé Plan Plan  
  • ·Index

    Page :53

    

• Results of Expert Meetings

  • ·Depression and ischemic heart disease: What have we learned so far and what must we do in the future?

    Page :54-78

    Wei Jiang, Alexander Glassman, Ranga Krishnan, Christopher M. O'Connor, Robert M. Califf

    Plan Plan  

• Clinical Investigations

  • ·Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial

    Page :79-88

    E. Magnus Ohman, Frans Van de Werf, Elliott M. Antman, Robert M. Califf, James A. de Lemos, C. Michael Gibson, Renee L. Oliverio, Lynn Harrelson, Carolyn McCabe, Peter DiBattiste, Eugene Braunwald, for the FASTER (TIMI 24) Investigators

    Résumé Résumé Plan Plan  
  • ·The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial

    Page :89-93

    Sorin J. Brener, A. Michael Lincoff, Eric R. Bates, Gang Jia, Paul W. Armstrong, Victor Guetta, Judith S. Hochman, Stefano Savonitto, Robert G. Wilcox, Harvey D. White, Eric J. Topol, for the GUSTO V Investigators

    Résumé Résumé Plan Plan  
  • ·Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease

    Page :94-101

    Arja T. Erkkilä, David M. Herrington, Dariush Mozaffarian, Alice H. Lichtenstein

    Résumé Résumé Plan Plan
  • ·Distal embolization during primary angioplasty: Histopathologic features and predictability

    Page :102-108

    Ugo Limbruno, Marco De Carlo, Sabina Pistolesi, Andrea Micheli, Anna Sonia Petronio, Tiziano Camacci, Gabriella Fontanini, Alberto Balbarini, Mario Mariani, Raffaele De Caterina

    Résumé Résumé Plan Plan  
  • ·Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease

    Page :109-115

    Oscar C. Marroquin, Kevin E. Kip, Suresh R. Mulukutla, Paul M. Ridker, Carl J. Pepine, Tjendimin Tjandrawan, Sheryl F. Kelsey, Sunil Mankad, William J. Rogers, C. Noel Bairey Merz, George Sopko, Barry L. Sharaf, Steven E. Reis

    Résumé Résumé Plan Plan  
  • ·Treatment with granulocyte colony–stimulating factor for mobilization of bone marrow cells in patients with acute myocardial infarction

    Page :115

    Friedhelm Kuethe, Hans R. Figulla, Michael Herzau, Matthias Voth, Michael Fritzenwanger, Thomas Opfermann, Katharina Pachmann, Andreas Krack, Herbert G. Sayer, Dietmar Gottschild, Gerald S. Werner

    Résumé Résumé Plan Plan  
  • ·Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide monotherapy in acute Myocardial Infarction (ADVANCE MI) trial

    Page :116-122

    The ADVANCE MI Investigators

    Résumé Résumé Plan Plan  
  • ·Comparison of losartan and captopril on heart failure–related outcomes and symptoms from the losartan heart failure survival study (ELITE II)

    Page :123-131

    Marvin A. Konstam, James D. Neaton, Philip A. Poole-Wilson, Bertram Pitt, Robert Segal, Divakar Sharma, Erik J. Dasbach, George W. Carides, Kenneth Dickstein, Günter Riegger, A. John Camm, Felipe A. Martinez, Deborah C. Bradstreet, Leila S. Ikeda, Emanuela P. Santoro, On behalf of the ELITE II investigators

    Résumé Résumé Plan Plan  
  • ·Depressive symptoms and inflammation among heart failure patients

    Page :132-136

    Amy K. Ferketich, Jeanette Pohorence Ferguson, Philip F. Binkley

    Résumé Résumé Plan Plan  
  • ·Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure

    Page :137-143

    Nicolas Lamblin, Sophie Susen, Joël Dagorn, Frédéric Mouquet, Brigitte Jude, Eric Van Belle, Christophe Bauters, Pascal de Groote

    Résumé Résumé Plan Plan  
  • ·Correction

    Page :143

    
  • ·Relationships among exercise capacity, hypertrophy, and left ventricular diastolic function in nonobstructive hypertrophic cardiomyopathy

    Page :144-149

    Afonso Y. Matsumoto, Edmundo Arteaga, Barbara M. Ianni, Ana M.F.W. Braga, Paula C. Buck, Charles Mady

    Résumé Résumé Plan Plan  
  • ·Randomized comparison of anterolateral versus anteroposterior electrode position for biphasic external cardioversion of atrial fibrillation

    Page :150-152

    Stephanos Siaplaouras, Axel Buob, Carsten Rötter, Michael Böhm, Jens Jung

    Résumé Résumé Plan Plan  
  • ·Depressed autonomic nervous system function in African Americans and individuals of lower social class: A potential mechanism of race- and class-related disparities in health outcomes

    Page :153-160

    Rachel Lampert, Jeannette Ickovics, Ralph Horwitz, Forrester Lee

    Résumé Résumé Plan Plan  
  • ·Prognostic value of electrocardiographic criteria for left ventricular hypertrophy

    Page :161-167

    Bill P. Hsieh, Michael X. Pham, Victor F. Froelicher

    Résumé Résumé Plan Plan  
  • ·Left ventricular diastolic function in normotensive subjects 2 months after acute myocardial infarction is related to glucose intolerance

    Page :168-174

    Abdul-Majeed Salmasi, Peter Frost, Mark Dancy

    Résumé Résumé Plan Plan
  • ·The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial

    Page :175-181

    Zefeng Zhang, John A. Spertus, Elizabeth M. Mahoney, Jean Booth, Fiona Nugara, Rodney H. Stables, William S. Weintraub

    Résumé Résumé Plan Plan  
  • ·Improved long-term survival associated with stent deployment during percutaneous coronary interventions: Results from a registry of 3399 patients

    Page :182-187

    Joseph B. Muhlestein, Jeffrey L. Anderson, ChangZong Cui, YanPing Lan, Tami L. Bair, T. Jared Bunch, Robert R. Pearson, Sherman G. Sorensen, Dale G. Renlund, Li Zhang, Benjamin D. Horne, G. Michael Vincent

    Résumé Résumé Plan Plan  
  • ·Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): Immediate and long-term results

    Page :188

    Alfredo E. Rodriguez, Maximo Rodriguez Alemparte, Carlos Fernandez Pereira, Cesar Federico Vigo, Alberto Sampaolesi, Victor Bernardi, Eugenio Marchand, Jorge Tronge, Igor F. Palacios, LASMAL II Investigators

    Résumé Résumé Plan Plan  
  • ·Angiotensin I–converting enzyme insertion/insertion genotype as a genetic risk factor for cardiovascular disease

    Page :e1

    Akiyoshi Ogimoto, Mareomi Hamada, Tetsuro Miki, Jitsuo Higaki

    
  • ·Reply to Ogimoto

    Page :e3

    Hsiang-Tai Chou, Chang-Hai Tsai, Fuu-Jen Tsai

    
  • ·Reply to Ogimoto, Angiotensin-converting enzyme inhibitors as a new therapy for atrial fibrillation? Controversy (Am Heart J 2005;149:e19.)

    Page :e5

    Azfar G. Zaman, Mark T. Kearney

    
  • ·Reply to Al-Shaer, Is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.)

    Page :e7

    Haralampos J. Milionis, Moses S. Elisaf

    
  • ·Azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome

    Page :e9

    Maurizio Gabrielli, Marcello Candelli, Luca Santarelli, Paolo Pola, Antonio Gasbarrini

    
  • ·Reply to Gasbarrini

    Page :e11

    Graham Hillis

    
  • ·Index

    Page :e13

    Michael J. Lim, J. Gerard Mudd, Morton J. Kern